RB-2121

N/A

Report date: 2023/02/18 10:44:32

NME

Base Information

Drug NameRB-2121

Drug Alias NameN/A

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionHIV replication inhibitors

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAventis +[2]

Active IndicationsN/A

Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A

Related LinksN/A